Schering Fails To Thwart Securities Suit Over Vytorin

Law360, New York (June 22, 2010, 6:28 PM EDT) -- A federal judge will not reconsider his decision to allow a securities suit alleging Schering-Plough Corp. hid or misstated the relatively poor performance of its anti-cholesterol drug Vytorin, even in light of the U.S. Supreme Court's decision in Ashcroft v. Iqbal.

The investors adequately pled their case, Judge Denis M. Cavanaugh of the U.S. District Court for the District New Jersey said in an order Monday that upheld an earlier order to allow the case to go forward.

Schering-Plough had asked the judge to reconsider his...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.